1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Assisted Reproductive Technology (ART) Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Assisted Reproductive Technology (ART) Devices Market, United States
3.1 Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 ART Media Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 ART Micropipettes Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033
3.2.1 ART Media Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 ART Micropipettes Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Assisted Reproductive Technology (ART) Devices Market, United States, Average Price ($), 2018-2033
3.4 Assisted Reproductive Technology (ART) Devices Market, United States, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in United States, Assisted Reproductive Technology (ART) Devices Market
4.1 CooperSurgical Inc
4.1.1 Company Overview
4.2 Wilson-Cook Medical Inc
4.2.1 Company Overview
4.3 Vitrolife AB
4.3.1 Company Overview
4.4 Fujifilm Biosciences Inc
4.4.1 Company Overview
5 Assisted Reproductive Technology (ART) Devices Market Pipeline Products6 Recent Developments
6.1 Corporate Communications
6.1.1 Oct 29, 2025: ASRM Receives $1 Million Donation from Dr. Kwang-Yul Cha for Reproductive Research Grants
6.1.2 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
6.1.3 Sep 15, 2025: Conceivable Raises $50 Million for Robotic IVF Embryo Lab Development
6.2 Government and Public Interest
6.2.1 Oct 24, 2025: US Fertility Research Team Highlights Innovation and Collaboration at the 2025 ASRM Scientific Congress
6.3 Other Significant Developments
6.3.1 Oct 29, 2025: ASRM Receives $1 Million Donation from Dr. Kwang-Yul Cha for Reproductive Research Grants
6.3.2 Oct 27, 2025: Granata Bio Corporation And Georgetown Equity Partners Form Joint Venture To Develop Next-Generation FSH
6.3.3 Oct 07, 2025: Valley Health Opens New Fertility Practice
6.3.4 Sep 26, 2025: SDFC Launches Summer Promotion for Discounted IVF
6.3.5 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
6.4 Product News
6.4.1 Nov 20, 2025: Overture Life Secures CE Mark Approval for Fertility Automation in Europe
6.4.2 Nov 03, 2025: Femasys Receives FDA Approval to Progress Final FemBloc Trial Phase and Secures $12 Million Financing
6.4.3 Oct 22, 2025: Femasys Initiates Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe
6.4.4 Oct 20, 2025: CaseBioscience Launches CaseBio Culture and Handling Media After FDA Clearance
6.4.5 Oct 13, 2025: CBIH Launches Women-Centric Fertility Innovation Using Nanoemulsion Delivery
6.4.6 Sep 30, 2025: Sona Launches Brand Partnerships Program, Offering Expecting Parents Over $300 in Perks
6.4.7 Sep 29, 2025: Oct Imaging Measures Cilia Beat Frequency in Human Fallopian Tubes
6.4.8 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
6.4.9 Sep 15, 2025: Conceivable Raises $50 Million for Robotic IVF Embryo Lab Development
6.4.10 Sep 11, 2025: Scientists Develop Steerable Microbots from Sperm Cells
6.4.11 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
6.4.12 Jun 18, 2025: Acupuncture Significantly Reduces Stress, Pain, and Anxiety for Patients Undergoing IVF
6.5 Strategy And Business Planning
6.5.1 Nov 18, 2025: IVI RMA North America Partners with Mid-Iowa Fertility
6.5.2 Oct 22, 2025: Femasys Initiates Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe
6.5.3 Oct 07, 2025: Valley Health Opens New Fertility Practice
6.5.4 Oct 06, 2025: LEVY Health Partners With IVF Academy USA to Enhance OB-GYN Training in Fertility Medicine
6.5.5 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: ART Media Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: ART Micropipettes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033
Table 5: ART Media Market, United States, Volume (Units), 2018-2033
Table 6: ART Micropipettes Market, United States, Volume (Units), 2018-2033
Table 7: Assisted Reproductive Technology (ART) Devices Market, United States, Average Price ($), 2018-2033
Table 8: Assisted Reproductive Technology (ART) Devices Market, United States, Company Share by Revenue ($m), 2025
Table 9: Assisted Reproductive Technology (ART) Devices Market Pipeline Products
Table 10: Total Number of Primary Research Participants, Reproductive Health Devices Market, by Country
List of Figures
Figure 1: Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: ART Media Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: ART Micropipettes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033
Figure 5: ART Media Market, United States, Volume (Units), 2018-2033
Figure 6: ART Micropipettes Market, United States, Volume (Units), 2018-2033
Figure 7: Assisted Reproductive Technology (ART) Devices Market, United States, Company Share (%), 2025